Literature DB >> 10374868

Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8.

G Dotti1, R Fiocchi, T Motta, B Facchinetti, B Chiodini, G M Borleri, G Gavazzeni, T Barbui, A Rambaldi.   

Abstract

Deep immunosuppression and Epstein-Barr virus (EBV) infection promote the emergence of lymphoproliferative disorders in patients undergoing solid organ transplantation. In the last few years a new herpesvirus, named human herpesvirus-8 (HHV-8), has been identified in Kaposi's sarcoma and primary effusion lymphoma (PEL) developing in AIDS patients. Subsequently, the same viral DNA sequences have been identified in almost all cases of Kaposi's sarcoma emerged outside HIV infection, thus suggesting their possible pathogenetic role in this tumor. Similarly, the association between HHV-8 and PEL also emerged in cases without HIV infection, even though the total number of these patients is still limited. Here, we focus on the emergence of this unusual lymphoma in patients undergoing solid organ transplant and underline once again its association with the HHV-8. Moreover, despite the characteristic local growth of this peculiar type of lymphoma, we demonstrate at the molecular level, an early neoplastic spread to the bone marrow suggesting the need to investigate in more detail the origin of the disease, as well as the molecular mechanisms controlling its systemic dissemination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10374868     DOI: 10.1038/sj.leu.2401390

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  20 in total

1.  Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient.

Authors:  C L Pérez; S Rudoy
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.

Authors:  Adriana Forero; Patrick S Moore; Saumendra N Sarkar
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

3.  Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.

Authors:  Debasmita Roy; Dirk P Dittmer
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

4.  Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cells.

Authors:  Adriana Forero; Kevin D McCormick; Frank J Jenkins; Saumendra N Sarkar
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

Review 5.  The radiological spectrum of pulmonary lymphoproliferative disease.

Authors:  S S Hare; C A Souza; G Bain; J M Seely; M M Gomes; M Quigley
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

6.  Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients.

Authors:  Jean-Philippe Emond; Anne-Geneviève Marcelin; Richard Dorent; Catherine Milliancourt; Nicolas Dupin; Camille Frances; Henri Agut; Iradj Gandjbakhch; Vincent Calvez
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

7.  Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  A Scott Laney; Jonathan S Peters; Susan M Manzi; Lawrence A Kingsley; Yuan Chang; Patrick S Moore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

8.  Three different histological subtypes of Epstein-Barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis C infection.

Authors:  Mikiko Kobayashi; Naoko Asano; Mana Fukushima; Takayuki Honda
Journal:  Int J Hematol       Date:  2014-05-31       Impact factor: 2.490

9.  Primary effusion lymphoma diagnosed by pericardiocentesis.

Authors:  Michael C Nemunaitis; Jeffrey M Schussler; S Michelle Shiller; Louis M Sloan; Robert G Mennel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-01

Review 10.  KSHV/HHV8-mediated hematologic diseases.

Authors:  Ethel Cesarman; Amy Chadburn; Paul G Rubinstein
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.